O’ConnorKCMcLaughlinKADe JagerPL, et al. Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med2007; 13: 211–217.
2.
BanwellBBennettJLMarignierR, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol2023; 22: 268–282.
3.
SechiEBuciucMPittockSJ, et al. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol2021; 78: 741–746.
4.
FlanaganEPGeschwindMDLopez-ChiribogaAS, et al. Autoimmune encephalitis misdiagnosis in adults. JAMA Neurol2023; 80: 30–39.
5.
WendelEMThonkeHSBertoliniA, et al. Temporal dynamics of MOG antibodies in children with acquired demyelinating syndrome. Neurol Neuroimmunol Neuroinflamm2022; 9: e200035.
6.
WatersPFaddaGWoodhallM, et al. Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes. JAMA Neurol2020; 77: 82–93.
7.
Cobo-CalvoARuizARollotF, et al. Clinical features and risk of relapse in children and adults with myelin oligodendrocyte glycoprotein antibody-associated disease. Ann Neurol2021; 89: 30–41.
8.
LuiAChongJFlanaganE, et al. High titers of myelin oligodendrocyte glycoprotein antibody are only observed close to clinical events in pediatrics. Mult Scler Relat Disord2021; 56: 103253.
9.
WatersPJKomorowskiLWoodhallM, et al. A multicenter comparison of MOG-IgG cell-based assays. Neurology2019; 92: e1250–e1255.
10.
CrossHSabiqFAckermansN, et al. Myelin oligodendrocyte glycoprotein (MOG) antibody positive patients in a multi-ethnic Canadian cohort. Front Neurol2020; 11: 525933.
